Poging GOUD - Vrij
The bar for successful obesity drugs has been rising sharply
Mint New Delhi
|January 02, 2025
Nothing else explains why Novo's stock fell after a drug test result
In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company's stock price to fall by as much as 29%. Yes, fall. For anyone not following the heated race for obesity drug dominance, it may look like we're living upside-down. After all, if this data were unveiled three years ago, the market reaction would have been wildly different. The stock might have gone up and headlines would have heralded an advance in the fight against obesity. But we're in a new era of obesity medicine. The bar for success, once modest, has soared—especially so for CagriSema. Let me explain.
Though Novo will make mind-blowing money from its existing obesity drugs in the coming years (its GLP-1 drugs are likely to become pharma's most lucrative franchise next year), CagriSema was seen as essential for continued growth in 2030 and beyond. And the study suggests it may not be the contender investors had hoped for.
Dit verhaal komt uit de January 02, 2025-editie van Mint New Delhi.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint New Delhi
Mint New Delhi
IDFC First settles ₹645-cr fraud case
IDFC First Bank said it has settled fraud claims at its Chandigarh branch of ₹645 crore and found no further discrepancies.
1 min
March 11, 2026
Mint New Delhi
Cabinet clears final IBC amendments
The Union cabinet on Tuesday approved the final amendments to the Insolvency and Bankruptcy Code (IBC), for which legislation will be moved in the Parliament in the ongoing session, two persons familiar with the development said.
2 mins
March 11, 2026
Mint New Delhi
Has Street already priced in AU's universal banking leap?
AU's universal banking transition should help sustain growth and reduce costs.
1 mins
March 11, 2026
Mint New Delhi
Edible oil buyers seek secure supply
If successful, model can improve warnings, disaster preparedness, agricultural planning
1 min
March 11, 2026
Mint New Delhi
Royal Orchid bets on both asset-light, ownership models
SE-listed Royal Orchid Hotels is pursuing measured expansion as India’s hospitality boom gathers pace, blending asset-light growth with selective ownership bets.
1 mins
March 11, 2026
Mint New Delhi
Trump says war to end 'very soon,' floats ending sanctions
US president insists operation was ahead of schedule, looks to shore up investors concerned about energy prices
2 mins
March 11, 2026
Mint New Delhi
Lego to expand in US amid robust spending
Lego reported record sales and profits for 2025.
1 mins
March 11, 2026
Mint New Delhi
THE GAP BETWEEN MUTUAL FUND RETURNS AND WHAT INVESTORS ACTUALLY EARN
But the data also showed something useful: 14 of the 18 funds beat the benchmark over the full period.
3 mins
March 11, 2026
Mint New Delhi
Why Iranian regime change would transform global energy markets
If the fight leads to regime change in Iran—a prospect that remains far from certain—it could one day reshape global energy markets. Lifting crippling economic sanctions could boost output in a country that already produces roughly 4% of the world’s oil.
5 mins
March 11, 2026
Mint New Delhi
Govt eyes tax on data usage to boost telecom revenues
Centre issued a direction to DoT at a 7 January a review meeting chaired by Prime Minister
3 mins
March 11, 2026
Listen
Translate
Change font size
